In this work, association between the presence and membrane density of CXCR4 and the effectiveness of mobilization was studied. Ninety G-CSF mobilized PBPC and 28 native BM (nBM) preparations obtained from healthy individuals for transplantation and BM obtained after G-CSF mobilized PBPC collection in 10 donors were investigated. Positivity for CD34, HLA-DR and CXCR4 were analysed in the three colour fluorescence. The cellular profile of PBPC differed from nBM preparations with respect to lower: (i) proportion of CD34 þ cells (0.64%70.04 vs 0.9270.07) and CD34 þ CXCR4 þ cells (0.30%70.02 vs 0.6170.07); (ii) contribution of CXCR4 þ cells to CD34 þ cells (52.2%72.5 vs 62.2%74.2); (iii) CXCR4 epitope density in CD34 þ cells (48.975.5 vs 94.7710.4). PBPC yield for CD34 þ cells was correlated with the content of CD34 þ cells lacking CXCR4 in the leukapheresis product (R ¼ 0.38). In contrast, nBM harvested for transplantation was poor in CD34 þ cells if these cells were frequently CXCR4À (R ¼ À0.49). The present study shows that CD34 þ cells mobilized to blood were characterized with a low proportion of CXCR4 and this associated with CD34 þ cell content in PBPC.
Introduction
In recent years, G-CSF mobilized PBPC from healthy donors have replaced BM in allogeneic transplantation in many situations.
1 G-CSF given to human subjects mobilizes CD34 þ cells from the marrow to blood. This is a complex process, which is only partially understood. The egress of CD34 þ cells from the BM is likely caused by a loss of adhesiveness of stem cells to stromal elements. 2 The adhesiveness is facilitated by an interaction between stromal derived factor 1 (SDF-1) and CXCR4 present on CD34 þ cells. 3, 4 It is suggested that in the murine system G-CSF reduces SDF-1 within the BM through degradation of the chemokine by proteolytic enzymes which are released by neutrophils during mobilization. 5 In addition, mobilized cells have a lower proportion of CXCR4 and lower density of this receptor 3, 6 and this correlates with the effectiveness of mobilization. [7] [8] [9] This effect could not, however, be solely attributed to G-CSF, as the latter papers were based on the observation of patients receiving both G-CSF and CY. Cytostatic treatment itself without G-CSF administration is able to mobilize CD34 þ cells to the blood. 10, 11 Moreover, cytostatics decrease the migratory capacity of CD34 þ cells which may confuse an analysis of correlation between CXCR4 positivity of CD34 þ cells and the yield of mobilization. 8 Therefore, to evaluate the relationship between the presence of CXCR4 on CD34 þ cells and the yield of CD34 þ cells harvest from mobilized blood or marrow, we analysed PBPC mobilized with G-CSF but not cytostatics and nBM obtained from healthy donors for our 85 patients receiving allogeneic haematopoietic stem cell transplantation during the years 1999-2002. Analysed CD34 þ cells were subdivided accordingly to the presence of HLA-DR epitope which is regulated by the state of differentiation. 12 This enabled us to evaluate whether the presence CXCR4 on CD34 þ cells plays a similar role in mobilization of multilineage and lineage restricted haematopoietic progenitor cells. Indeed, we found that the presence of CXCR4 on CD34 þ cells is inversely correlated with their egress to blood and this was seen in CD34 þ cells having and lacking membrane HLA-DR antigen.
Materials and methods

Materials
Ninety samples of G-CSF mobilized PBPC obtained from 39 HLA matched family donors and from 19 matched unrelated donors were used for 58 allotransplants in 57 patients (six children and 51 adults). Donors received G-CSF (Neupogen, Filgrastim, Roche, Basel, Switzerland) usually at a dose of 5 mg/kg b.w. twice daily beginning 5 days before the first leukapheresis, and G-CSF administration was continued if a second leukapheresis was needed. Sixty-seven leukaphereses were performed in our facility with the use of a COBE Spectra continuous flow separator (COBE BCT Inc., Blood Component Technology, Lakewood, CO, USA) and 23 PBPC for 19 patients were obtained from foreign donor centres. The volume of processed blood varied from 2.8 to 11.4 l (mean7s.e.m.: 8.1 l70.3).
Native BM from 28 sibling or unrelated donors was collected under general anaesthesia in our facility or in foreign donation centres. In 10 healthy sibling donors just after PBPC collection the marrow was obtained by iliac crest aspiration. All PBPC, nBM and mBM preparations, regardless of origin, were analysed in our laboratory according to our standard protocol. The above study was approved by the Local Ethics Committee (Medical School, Wroclaw, Poland). All marrow donors gave written informed consent.
Flow cytometry
A FACS Calibur flow cytometer (Becton Dickinson, Mountain View, CA, USA) was used for the detection and enumeration of CD34 þ cells, their HLA-DR þ and HLA-DRÀ subsets, and the presence of CXCR4 positive cells. Cells were labeled as previously described. 13 Data acquisition and analysis were performed using Cellquest, PC-Lysis (Version 1.0, BD) and WinMDI (version 2.8) softwares. The Leuco-GATE Monoclonal (Mo) Abs mixture -CD45 FITC/CD14 PE was used to gate pure leukocytes populations; FITC-conjugated anti-HLA-DR (Clone L243), PE-conjugated anti-CXCR4 (Clone 12G5) and Peridinin chlorophyll protein (PerCP)-conjugated anti-CD34 (Clone 8G12) MoAbs -for description of progenitor cells; and PerCP-conjugated Mouse IgG1 for isotypic control (all MoAbs were purchased from BectonDickinson, Erembodegen, Belgium).
Statistical analysis
Statistical analysis was performed using the CSS Statistica for Windows (version 5.0). software (Sta-Soft Inc., Tulsa, OK, USA). Mann-Whitney U-Test, for nonparametric, unpaired samples and The Wilcoxon Matched-Pairs Test, was used for computing differences between investigated groups. Spearman R was used for computing correlation coefficient. Differences between samples were considered significant at Po0.05.
Results
Native BM harvested from iliac crest for transplantation had a higher proportion of CD34 þ CXCR4 þ cells as compared to PBPC (mean7s.e.m.: 0.61%70.07 vs 0.29%70.02, Po0.001, Table 1 ). PBPC CD34 þ cells were less frequently CXCR4 positive than those in nBM (52.2%72.5 vs 62.2%74.2, P ¼ 0.04, Figure 1a) . Notably, proportions of CD34 þ cells in transplant material harvested from blood or from the iliac crest were associated with fractions of CD34 þ cells lacking or having CXCR4, Figure 2a ). In contrast, nBM harvested for transplantation were poorer in CD34 þ cells if these cells were frequently CXCR4 negative (R ¼ À0.49, P ¼ 0.005, Figure 2b ). To understand the above associations in 10 donors which received G-CSF for PBPC collection their marrows (mobilized BM (mBM)) were harvested just after separation. mBM had lower proportions of CD34 þ CXCR4 þ cells as compared to PBPC obtained from the same G-CSF mobilized donors (0.06%70.01 vs 0.26%70.04 for mBM and PBSC, respectively, P ¼ 0.005, Table 1 ) mainly due to the lower contribution of CXCR4 þ cells to the whole pool of CD34 þ cells in mBM as compared to PBPC (22.8%75.8 vs 52.1%78.2, P ¼ 0.007, Figure 1b) . Native BM CD34 þ cells subpopulations (defined on the basis of CXCR4 and/or HLA-DR coexpression) had a higher density of CXCR4 epitope than those in mBM and PBPC (Figure 3a) . This was seen irrespective of whether CXCR4 MFI were measured in all CD34 þ cells or in CD34 þ cells expressing or not HLA-DR (Figure 3a) .
Lower proportions of CD34 þ CXCR4 þ cells in PBPC meant that patients received less CD34 þ CXCR4 þ cells when transplanted with PBPC than with marrow (2.6270.4 Â 10 6 /kg vs 2.9970.7 Â 10 6 /kg for PBSC and nBM, respectively, Table 1 ).
Discussion
In a number of studies the role of neutrophils in mobilization of CD34 þ cells was documented. 5, 14 It was postulated that this mechanism relies on degradation of SDF-1 within the BM stroma by proteolytic enzymes released by neutrophils activated during mobilization. 5, 15 However, the interaction between stromal cells and haematopoietic progenitors must be more complex as in physiological situations, with normal numbers and functions of neutrophils, a proportion of CD34 þ cells is constitutively released to replace progenitors in some freed marrow niches. 16 Therefore, in the present study, we focused on the presence of CXCR4 (SDF-1 receptor) on CD34 þ cells to verify the role of regulation of CXCR4 expression in mobilization of haematopoietic progenitors to the peripheral blood. This hypothesis was already supported by a study of Voermans et al 8 which showed a negative correlation between CXCR4 expression and mobilization of CD34 þ cells in patients receiving chemotherapy and G-CSF. However, from the latter results it cannot be concluded whether G-CSF alone or only given together with cytostatics is responsible for lowering of CXCR4 membrane expression. Therefore, in this study, the membrane expression of CXCR4 on CD34 þ cells was studied in steady-state (nBM) and G-CSF mobilized marrow and in PBPC obtained from healthy haematopoietic stem cells donors.
We documented that (i) CD34 þ cells in PBPC had a lower proportion of CXCR4 þ and (ii) the membrane expression of this receptor, determined as mean fluorescence density, was decreased after completion of G-CSF mobilization. Therefore, we provide an evidence that G-CSF alone but not in concert with cytostatics is able to regulate the expression of CXCR4 on CD34 þ cells. This observation was valid for all CD34 þ cell subpopulations having and lacking HLA-DR antigen (Figure 3) . Therefore, G-CSF regulates the expression of CXCR4 þ in CD34 þ cells irrespective of their stage of differentiation. Mean Fluorescence Intensity (MFI) measurements showed that density of CXCR4 epitope on CD34 þ cells exhibited a wide range of values in both HLA-DR þ and HLA-DRÀ subpopulations (Figure 3) . Aiuti et al 6, 17 also showed that CXCR4 density gradually decreases in cell subpopulations down to the level recognized as beyond the level of positivity. In the present work, we found that, under G-CSF treatment CXCR4 membrane density gradually decreased on CD34 þ cells irrespective of their primary density upon cell membranes.
In this study, we documented that G-CSF alone is able to modify the density of CXCR4 on CD34 þ cells. However, the most intriguing question was whether this phenomenon has a biological significance for CD34 þ cell mobilization.
To address this question, we looked at the presence of CXCR4 þ cells on CD34 þ cells in marrow populations in healthy individuals not receiving (nBM) and receiving G-CSF (mBM). We found that marrow CD34 þ cells of individuals on G-CSF had a lower proportion of CXCR4 and lower density of this receptor as compared to native marrow cells. Importantly, the content of CD34 þ cells in marrow harvested for transplantation was correlated with the proportion of CD34 þ having CXCR4. All these observations support the notion that CXCR4 docks CD34 þ cells in the marrow and lowering of this receptor density under G-CSF treatment associates with egress of CD34 þ cells to blood. Indeed, the yield of mobilization (proportion of CD34 þ cells in PBPC) correlated with the presence of CD34 þ cells lacking CXCR4 (Figure 2a) . Therefore, homing of CD34 þ cells is associated with the level of CXCR4 positivity, which is in line with the current understanding of SDF-1 as a main force attracting CD34 þ CD34 and CXCR4 positivity in BM and PBPC D Dlubek et al cells to reside. Mobilization can be seen as a mirror image of homing. Therefore, our observation lends additional credit to the assumption that mobilization depends largely on the modification of CXCR4 density on CD34 þ cells. The mechanism of this modification may be similar (enzyme digestion) to that proposed for lowering of SDF-1 density upon G-CSF treatment. 5, 14 However, the regulation may be more complex including modification of CXCR4 gene expression and/or protein synthesis directly or indirectly by G-CSF which promote entering the cells to the growth cycle. 18 Regulation of CXCR4 expression at the level of translation or protein synthesis was already shown for mesenchymal stem cells which may have CXCR4 transcripts but lack CXCR4 on the membrane. 19 Taken together, we showed that G-CSF mobilization associates with the lowering of CXCR4 epitope density and that process correlates with the yield of CD34 þ cells harvested in PBPC.
